TERT and cancer: Most telomerase inhibitors might be effective to treat several cancer types, such as prostate, lung, breast, colorectal, and haematological malignancies, which rarely harbour TERT promoter mutations but display strong telomerase activity mainly depending on chromosomal rearrangements and TERT gene amplification (Dratwa et al., 2020).